Mayne Pharma Group Stock Market Value
| MAYNF Stock | USD 2.62 0.01 0.38% |
| Symbol | Mayne |
Mayne Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mayne Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mayne Pharma.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Mayne Pharma on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Mayne Pharma Group or generate 0.0% return on investment in Mayne Pharma over 30 days. Mayne Pharma is related to or competes with Bristol Myers, AbbVie, Merck, Gilead Sciences, Johnson Johnson, and Amgen. Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutica... More
Mayne Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mayne Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mayne Pharma Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 15.69 | |||
| Value At Risk | (4.76) | |||
| Potential Upside | 4.94 |
Mayne Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mayne Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mayne Pharma's standard deviation. In reality, there are many statistical measures that can use Mayne Pharma historical prices to predict the future Mayne Pharma's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (6.90) |
Mayne Pharma Group Backtested Returns
Mayne Pharma Group has Sharpe Ratio of -0.0829, which conveys that the firm had a -0.0829 % return per unit of risk over the last 3 months. Mayne Pharma exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mayne Pharma's Mean Deviation of 1.16, risk adjusted performance of (0.05), and Standard Deviation of 2.44 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0269, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Mayne Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mayne Pharma is expected to be smaller as well. At this point, Mayne Pharma Group has a negative expected return of -0.2%. Please make sure to verify Mayne Pharma's total risk alpha, and the relationship between the standard deviation and kurtosis , to decide if Mayne Pharma Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.28 |
Poor predictability
Mayne Pharma Group has poor predictability. Overlapping area represents the amount of predictability between Mayne Pharma time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mayne Pharma Group price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Mayne Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Mayne Pharma Group lagged returns against current returns
Autocorrelation, which is Mayne Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mayne Pharma's pink sheet expected returns. We can calculate the autocorrelation of Mayne Pharma returns to help us make a trade decision. For example, suppose you find that Mayne Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mayne Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mayne Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mayne Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mayne Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Mayne Pharma Lagged Returns
When evaluating Mayne Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mayne Pharma pink sheet have on its future price. Mayne Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mayne Pharma autocorrelation shows the relationship between Mayne Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Mayne Pharma Group.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Mayne Pink Sheet
Mayne Pharma financial ratios help investors to determine whether Mayne Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mayne with respect to the benefits of owning Mayne Pharma security.